Aethlon Medical, Inc. (AEMD) |
1.1 0.09 (8.91%)
|
06-26 19:41 |
Open: |
1.07 |
Pre. Close: |
1.01 |
High:
|
1.12 |
Low:
|
1.0501 |
Volume:
|
455,041 |
Market Cap:
|
17(M) |
|
|
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California. |
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
1.12 - 1.13 |
1.13 - 1.13 |
Low:
|
1.04 - 1.04 |
1.04 - 1.05 |
Close:
|
1.09 - 1.1 |
1.1 - 1.11 |
|
Technical analysis |
as of: 2022-06-24 4:37:49 PM |
Overall:
|
|
Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
Target: |
Six months: 1.63 One year: 2 |
Support: |
Support1: 0.88 Support2: 0.74 |
Resistance: |
Resistance1: 1.4 Resistance2: 1.72 |
Pivot: |
1.04  |
Moving Average: |
MA(5): 1.01 MA(20): 1.1 
MA(100): 1.24 MA(250): 2.44  |
MACD: |
MACD(12,26): -0.1 Signal(9): -0.1  |
Stochastic oscillator: |
%K(14,3): 40.8 %D(3): 30  |
RSI: |
RSI(14): 49.9  |
52-week: |
High: 6.21 Low: 0.87 |
Average Vol(K): |
3-Month: 387 (K) 10-Days: 276 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ AEMD ] has closed below upper band by 29.4%. Bollinger Bands are 28.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Headline News |
Thu, 23 Jun 2022 Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace
Wed, 22 Jun 2022 StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD) - Defense World
Tue, 21 Jun 2022 Aethlon Medical, Inc. (AEMD) Up 6.25% in Premarket Trading - InvestorsObserver
Fri, 17 Jun 2022 Is Aethlon Medical, Inc. (AEMD) Stock About to Get Hot Friday? - InvestorsObserver
Fri, 10 Jun 2022 Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update - Defense World
Mon, 06 Jun 2022 Investment Analysts' New Coverage for June 6th (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) - Defense World
|
Financial Analysis |
Price to Book Value: |
Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Underperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Underperform |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Underperform |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Neutral |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NASDAQ |
Sector: Healthcare |
Industry: Medical Devices |
Shares Out. |
0 (M) |
Shares Float |
15 (M) |
% Held by Insiders
|
1.527e+007 (%) |
% Held by Institutions
|
0.7 (%) |
Shares Short
|
9 (K) |
Shares Short P.Month
|
0 (K) |
Stock Financials |
EPS
|
-8.79e+006 |
EPS Est Next Qtl
|
0 |
EPS Est This Year
|
-0.5 |
EPS Est Next Year
|
-2 |
Book Value (p.s.)
|
0 |
Profit Margin (%)
|
0 |
Operating Margin (%)
|
-2 |
Return on Assets (ttm)
|
822.2 |
Return on Equity (ttm)
|
-32.2 |
Qtrly Rev. Growth
|
315280 |
Gross Profit (p.s.)
|
-117.23 |
Sales Per Share
|
-67.03 |
EBITDA (p.s.)
|
794096 |
Qtrly Earnings Growth
|
-0.7 |
Operating Cash Flow
|
0 (M) |
Levered Free Cash Flow
|
-9 (M) |
Stock Valuations |
PE Ratio
|
-0.01 |
PEG Ratio
|
0 |
Price to Book value
|
0 |
Price to Sales
|
-0.02 |
Price to Cash Flow
|
0.68 |
Stock Dividends |
Dividend
|
0 |
Forward Dividend
|
23040 |
Dividend Yield
|
0% |
Dividend Pay Date
|
2019-10-14 |
Ex-Dividend Date
|
Invalid DateTime. |
7 Binary Options
|
Your Ad Here
|
|